Milestone cancer vaccine success leaves hard questions unanswered

T1Covered by 1 source · first reported by Nature / Science / Nature Biotechnology at 26 Oct, 05:25 UTC

mRNA vaccine from Merck and Moderna slashes risk of melanoma’s return, but why remains unclear

Sources

• T1Milestone cancer vaccine success leaves hard questions unansweredNature / Science / Nature Biotechnology26 Oct, 05:25